Celsion Corp (CLSN)

1.05
-0.02(-1.87%)
After Hours
1.04
-0.01(-0.952%)
- Real-time Data
  • Volume:
    1,132,394
  • Bid/Ask:
    1.04/1.08
  • Day's Range:
    1.03 - 1.08

CLSN Overview

Prev. Close
1.07
Day's Range
1.03 - 1.08
Revenue
480K
Open
1.06
52 wk Range
0.431 - 6.5
EPS
-0.69
Volume
1,132,394
Market Cap
90.89M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
12,835,001
P/E Ratio
-
Beta
1.96
1-Year Change
-11.57%
Shares Outstanding
86,557,736
Next Earnings Date
May 14, 2021
What is your sentiment on Celsion Corp?
or
Market is currently closed. Voting is open during market hours.

Celsion Corp News

Celsion Corp Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Celsion Corp Company Profile

Celsion Corp Company Profile

Employees
27

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).

Read More
  • Any new info on this stock? Will it ever reach 5$ again? Many thanks
    0
    • 🚀🚀🚀🚀🚀🚀
      0
      • Takeover certain Target $3.5
        0
        • Please elaborate :)
          0
      • this one is getting crushed
        0
        • reverse stock split
          0
          • stock market = 🤬🤡
            0
            • Does anyone know about the stock status? Will it go bankrupt? Do they have problems?
              0
              • Man all stock market is red what do you expecting for?
                0
                • aftermarket movement, breathing again
                  2
                  • this rocket 🚀 is loaded... and fuel up to the max... please someone... drop the match and set it off...
                    0
                    • strange how this stock is going down with positive earnings. 🤔
                      0
                      • positive earning ? do you mean less negative earning then expected ?
                        3
                      • Mehmet MehmetDespite reporting EPS this morning for 2020 that beat analyst expectations and revenue that was in-line, Celsion shares are struggling this afternoon.
                        0
                      • Mehmet MehmetDespite reporting EPS this morning for 2020 that beat analyst expectations and revenue that was in-line, Celsion shares are struggling this afternoon.🙄
                        0
                    • I have a question, any insight would be appreciated. I few hundred shares, would it be wise to pick up more, from an investment point of view?
                      0
                      • yes grab more asap
                        0
                    • nice to see celsion moving up again. This one is long term, but a huge payout. once they get FDA approval, they can go to $20 or more.I could be being very conservative as they were $7k per share in the early 2,000's. I see Celsion coming back with a Vengeance. it's just going to take some time.
                      0
                      • When they release they curre it will boom ... just watch
                        0
                        • bought again this morning
                          0
                          • Moving???Thoughts?
                            0
                            • Well, waiting for some news, then as always it will jump 30%+
                              0
                            • 🤦‍♂️ cant wait to get rid of this stock
                              1
                            • derek ketcherBuy and hold 🚀😎this is the way🚀😎🦍🌝🪐🍌
                              0
                          • Some bad news arrived?
                            2
                            • No, same happening for ATOS also
                              0
                            • It's all stocks. market's going through a correction. I've noticed today it's trending back up, just probably giving us a breather🥴
                              0
                          • Perfect buying opportunity, will go up to $2.30
                            1
                            • https://apnews.com/press-release/globe-newswire/technology-business-chemotherapy-corporate-news-drug-trials-bdcc8ed5dec969a4cea84a7d4736fc41
                              0
                              • not sure any news helps this stock haha...hopefully though
                                0
                            • Do you guys having any positive or negative news about this one? It's pretty static
                              1
                              • it doesn't move very far up or down, based on all the good news for this company however it doesn't seem to have affected the stock that much, if anything the good news lowered the stock a little. But hopefully in the near future this stock should increase. I really have no idea however, nothing thats happened with this stock has made any sense.
                                0
                              • I believe they are in the last leg of a couple of trials to get FDA approvals.
                                0
                              • Lisa WatkinsFingers crossed
                                0
                            • buy and hold
                              0
                              • celsion to the moon
                                1
                                • It seems like good news hurts this stock...which makes absolutely no sense.
                                  0
                                  • I keep thinking the same thing!!
                                    0
                                • new report about their trial...not sure if that'll move this stock
                                  0
                                  • Why?
                                    0
                                • once it breaks $2.5, it will immediately jump to $3.0
                                  0
                                  • derek ketcher because of $2.5 strike price options.
                                    1
                                  • is that some level 2 data ****..im still a bit green on stock trading
                                    0
                                  • it was already at 3.0, 3.2 actually, then took a nose dive.
                                    0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.